RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16651634http://www.w3.org/2000/01/rdf-schema#comment"Benign peripheral nerve tumors called neurofibromas are a major source of morbidity for patients with neurofibromatosis type 1. Some neurofibroma Schwann cells aberrantly express the epidermal growth factor receptor (EGFR). In a mouse model in which the CNPase promoter drives expression of human EGFR in Schwann cells, nerves develop hypertrophy, mast cell accumulation, collagen deposition, disruption of axon-glial interactions, characteristics of neurofibroma and are hypoalgesic. Administration of the EGFR antagonist cetuximab (IMC-C225) for 2 weeks beginning at birth in CNPase-hEGFR mice normalized all pathologies at 3 months of age as evaluated by hotplate testing or histology and by electron microscopy. Mast cell chemoattractants brain-derived neurotrophic factor, monocyte chemoattractant protein-1, and transforming growth factor-beta1, which may account for mast cell accumulation and fibrosis, were reduced by cetuximab. Later treatment was much less effective. A birth to 2-week pulse of cetuximab blocked hEGFR phosphorylation and Schwann cell prolifera-tion in perinatal mutant nerve, so CNPase-hEGFR Schwann cell numbers correlate with the cetuximab effect. A >250-fold enlarged population of EGFR(+)/p75(+) cells was detected in newborn Nf1(+/-) mouse nerves. These results suggest the existence of an EGFR(+) cell enriched in the perinatal period capable of driving complex changes characteristic of neurofibroma formation."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.org/dc/terms/identifier"doi:10.2353/ajpath.2006.050859"xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Wu J."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Monk K.R."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Tedesco S."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Williams J.P."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Fitzgerald M.E."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Ratner N."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/author"Crimmins J.T."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/date"2006"xsd:gYear
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/name"Am J Pathol"xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/pages"1686-1696"xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/title"Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma."xsd:string
http://purl.uniprot.org/citations/16651634http://purl.uniprot.org/core/volume"168"xsd:string
http://purl.uniprot.org/citations/16651634http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16651634
http://purl.uniprot.org/citations/16651634http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16651634
http://purl.uniprot.org/uniprot/#_A0A1W2P863-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_A8IP97-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_A6JPX8-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_A6JPX9-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_E7CXR8-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_E7CXR9-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_Q3TYD2-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634
http://purl.uniprot.org/uniprot/#_Q04690-mappedCitation-16651634http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16651634